Hospital Clínic de Barcelona, officially Hospital Clínic i Provincial de Barcelona, is a university hospital founded in 1906 and based in Barcelona. It opened its doors on December 23, 1906, with a capacity of 400 patients, some of which were moved from Hospital de la Santa Creu.

There are 819 beds in Hospital Clínic i Provincial; Servicio de Oncología.

During the past decade, Hospital Clínic i Provincial; Servicio de Oncología conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 10 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínic i Provincial; Servicio de Oncología" #1 sponsor was "Hoffmann-La Roche" with 22 trials, followed by "EMD Serono Research & Development Institute, Inc." with 3 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "G1 Therapeutics, Inc." with 2 trials sponsored and "Clovis Oncology, Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínic i Provincial; Servicio de Oncología" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Agensys, Inc." with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínic i Provincial; Servicio de Oncología" are "Breast Cancer" (4 trials), "Renal Cell Carcinoma" (4 trials), "Small Cell Lung Cancer" (2 trials), "Urothelial Carcinoma" (2 trials) and "Advanced BRAFV600 Wild-type Melanoma" (1 trials). Many other conditions were trialed in "Hospital Clínic i Provincial; Servicio de Oncología" in a lesser frequency.

Most popular intervention types in "Hospital Clínic i Provincial; Servicio de Oncología" are "Drug" (30 trials), "Other" (3 trials), "Biological" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (15 trials), "Placebo" (10 trials), "Carboplatin" (7 trials), "Cisplatin" (6 trials) and "Bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínic i Provincial; Servicio de Oncología" are 25 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Clínic i Provincial; Servicio de Oncología". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Hospital Clínic i Provincial; Servicio de Oncología, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínic i Provincial; Servicio de Oncología, 3 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".